GSK’s blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was better than an existing treatment on the market, the company said on Monday. Oncology is a key area of focus for GSK as a standalone prescription medicine and vaccine business and its shares fell 3 percent after…

Previous monoclonal antibody treatments against COVID-19 have had mixed results against variants. However, new research uncovered two antibodies that work against all known strains of COVID-19. STORY AT-A-GLANCE Two antibodies have been uncovered that are so effective at neutralizing COVID-19 — and all of its variants — that they believe the antibodies could serve as…

A team of 19 scientists from the United Kingdom have published new research that helps explain why countries with the highest vaccination rates are experiencing the highest numbers of what they call “breakthrough infections,” as well as reinfection with other variants of COVID-19. This research article, published on June 14, 2022 in the peer-reviewed journal…

Findings from a study in Sweden provide one possible explanation for why some health care workers who were in contact with COVID-19 patients every day remain uninfected, even though they were not vaccinated against the disease. “The reason why some of the staff did not contract the disease seems to have been that IgA (immunoglobulin…

FRANKFURT, GERMANY—German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, likely reducing treatment options if the new variant prevails. Two groups of Germany based scientists separately found that protection from GlaxoSmithKline and Vir’s antibody cocktail…

New research from the University of California San Francisco (UCSF) and University of Minnesota (UMN) suggest that individuals who have recovered from COVID-19 should still receive one vaccination shot. The research from UCSF was published on Sept. 25. Scientists evaluated the humoral and cell-mediated response elicited by the Pfizer-BioNTech vaccine in individuals who had contracted COVID-19 and those who…

News Analysis Real-world data is not showing antibody-dependent enhancement of disease occurring in COVID-19 vaccinated populations, Dr. Jay Bhattacharya said in an interview on The Sharyl Attkisson Podcast on Sunday. Antibody-dependent enhancement (ADE), also known as vaccine-enhanced disease, occurs when certain antibodies produced by a vaccine don’t protect an individual from infection but enhances viral…

A UK-wide antibody testing programme is to be launched for people who have contracted coronavirus, the government has announced. The programme, which will offer tests to thousands of adults per day, aims to improve understanding and gain “vital” data about antibody protection following COVID-19 infection and vaccination. From Tuesday, anyone over 18 from any of…

Evacuation efforts have flown 13,000 Americans and Afghans out of Afghanistan since last week, people trying to evacuate must escape both the Taliban and the shooting that takes place right outside the airport, and a monoclonal antibody treatment for COVID-19 is gaining traction in Florida.

A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than the Chinese CoronaVac vaccine made by Sinovac. The study reported that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac. The…